 |
인쇄하기
취소
|
Samil, Boehringer Ingelheim strengthens strategic alliance
Samil Pharm said it has joined hands with Boehringer Ingelheim Korea to market Mirapex (pramipexole), a medication indicated for treating early-stage Parkinson’s disease and restless legs syndrome (RLS)
Samil has recently signed an exclusive distribution agreement with Boehringer Ingelheim Korea for Mirapex in Korea, as well as the latter’s once-daily controlled release form, as part of its ...
Samil has recently signed an exclusive distribution agreement with Boehringer Ingelheim Korea for Mirapex in Korea, as well as the latter’s once-daily controlled release form, as part of its ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.